Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Appointed CFO Quarterly results Acq. announced Director departure CC transcript Employment agrmnt Notes underwriting agrmnt Appointed director
|
COGENTIX MEDICAL INC (CGNT)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
04/24/2018 |
8-K
| Quarterly results |
03/12/2018 |
8-K
| Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other E...
Docs:
|
"Agreement and Plan of Merger, by and among LM US Parent, Inc., Camden Merger Sub, Inc. and Cogentix Medical, Inc",
"Amendment to Amended and Restated By-laws of Cogentix Medical, Inc",
"Tender and Support Agreement, by and among LM US Parent, Inc., Camden Merger Sub, Inc. and Lewis C. Pell",
"Tender and Support Agreement, by and among LM US Parent, Inc., Camden Merger Sub, Inc. and Accelmed Growth Partners, L.P",
"Cogentix Medical Enters Definitive Merger Agreement to",
"Email communication to employees of Cogentix Medical, Inc." |
|
02/06/2018 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
11/07/2017 |
8-K
| Quarterly results |
08/01/2017 |
8-K
| Quarterly results |
07/18/2017 |
8-K
| Quarterly results |
06/06/2017 |
8-K
| Form 8-K - Current report |
05/24/2017 |
8-K
| Form 8-K - Current report |
05/02/2017 |
8-K
| Form 8-K - Current report |
03/24/2017 |
8-K
| Form 8-K - Current report |
03/09/2017 |
8-K
| Form 8-K - Current report |
01/06/2017 |
8-K
| Form 8-K - Current report |
12/29/2016 |
8-K/A
| Form 8-K/A - Current report [Amend] |
11/08/2016 |
8-K
| Quarterly results
Docs:
|
"MINNEAPOLIS, MN, November 8, 2016 – Cogentix Medical, Inc. , a global medical device company with innovative and proprietary products serving urology and airway management markets, today reported financial results for the third quarter ended September 30, 2016. In addition, on November 3, 2016, shareholders approved transactions to convert all of the Company’s outstanding debt and accrued interest into equity and issue 16.1 million shares to Accelmed Growth Partners, L.P. for $25 million. The transactions approved by the shareholders closed on November 3, 2016, and as a result, are not reflected in the financial results described below." |
|
11/04/2016 |
8-K
| Form 8-K - Current report |
09/12/2016 |
8-K
| Form 8-K - Current report |
09/07/2016 |
8-K
| Form 8-K - Current report |
08/18/2016 |
8-K
| Form 8-K - Current report |
08/02/2016 |
8-K
| Form 8-K - Current report |
07/22/2016 |
8-K
| Form 8-K - Current report |
07/12/2016 |
8-K
| Form 8-K - Current report |
06/22/2016 |
8-K
| Form 8-K - Current report |
06/15/2016 |
8-K
| Form 8-K - Current report |
06/06/2016 |
8-K
| Form 8-K - Current report |
05/27/2016 |
8-K
| Amended existing or entered into new employment agreement with an officer |
05/05/2016 |
8-K
| Quarterly results |
04/11/2016 |
8-K
| Form 8-K - Current report |
03/30/2016 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
03/29/2016 |
8-K
| Form 8-K - Current report |
03/03/2016 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
02/19/2016 |
8-K
| Shareholder Nominations Pursuant to Exchange Act Rule 14a-11, Other Events |
02/03/2016 |
8-K
| Results of Operations and Financial Condition, Departure of Directors or Certain Officers; Election of Directors; Appointment... |
01/08/2016 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
12/11/2015 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and ... |
|
|
|